Mindfulness-based cognitive therapy for people with diabetes and emotional problems: long-term follow-up findings from the DiaMind randomized controlled trial.
Study Goal
The researchers aimed to determine if the benefits of mindfulness-based cognitive therapy (MBCT) on emotional distress in people with diabetes would be sustained six months after the intervention.
Results Summary
MBCT showed sustained reductions in perceived stress, anxiety, and depressive symptoms (HADS) at six-month follow-up, but no significant effects on diabetes distress or HbA1c. The effects were statistically significant with moderate to large effect sizes, though POMS depressive symptoms did not remain significant after multiple testing correction.
Population
139 outpatients with diabetes (type-I or type-II) and lowered emotional well-being.
Effective Dosage
Not specified
Duration
Not specified (follow-up was six months post-intervention)
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) | decrease | perceived stress | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | p<.001, d=.76 | showed sustained reductions | #1 |
mindfulness-based cognitive therapy (MBCT) | decrease | anxiety (assessed by HADS) | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | p<.001, d=.83 | showed sustained reductions | #2 |
mindfulness-based cognitive therapy (MBCT) | decrease | anxiety (assessed by POMS) | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | p<.001, d=.92 | showed sustained reductions | #3 |
mindfulness-based cognitive therapy (MBCT) | decrease | HADS depressive symptoms | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | p=.004, d=.51 | showed sustained reductions | #4 |
mindfulness-based cognitive therapy (MBCT) | no change | POMS depressive symptoms | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | p=.016, d=.48 | showed no significant between-group effect | #5 |
mindfulness-based cognitive therapy (MBCT) | no change | diabetes distress | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | - | showed no significant between-group effect | #6 |
mindfulness-based cognitive therapy (MBCT) | no change | HbA1c | outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being | - | showed no significant between-group effect | #7 |
OBJECTIVE: The DiaMind trial showed beneficial immediate effects of mindfulness-based cognitive therapy (MBCT) on emotional distress, but not on diabetes distress and HbA1c. The aim of the present report was to examine if the effects would be sustained after six month follow-up. METHODS: In the DiaMind trial, 139 outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being were randomized into MBCT (n=70) or a waiting list with treatment as usual (TAU: n=69). Primary outcomes were perceived stress, anxiety and depressive symptoms, and diabetes distress. Secondary outcomes were, among others, health status, and glycemic control (HbA1c). RESULTS: Compared to TAU, MBCT showed sustained reductions at follow-up in perceived stress (p<.001, d=.76), anxiety (p<.001, assessed by HADS d=.83; assessed by POMS d=.92), and HADS depressive symptoms (p=.004, d=.51), but not POMS depressive symptoms when using Bonferroni correction for multiple testing (p=.016, d=.48). No significant between-group effect was found on diabetes distress and HbA1c. CONCLUSION: This study showed sustained benefits of MBCT six months after the intervention on emotional distress in people with diabetes and a lowered level of emotional well-being. TRIAL REGISTRATION: Dutch Trial Register NTR2145, http://www.trialregister.nl.